Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CTLA4 Antikörper

Der Maus Monoklonal Anti-CTLA4-Antikörper wurde für FACS, WB und IF validiert. Er ist geeignet, CTLA4 in Proben von Human zu detektieren.
Produktnummer ABIN6937038

Kurzübersicht für CTLA4 Antikörper (ABIN6937038)

Target

Alle CTLA4 Antikörper anzeigen
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Reaktivität

  • 152
  • 84
  • 45
  • 14
  • 3
Human

Wirt

  • 90
  • 80
  • 22
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Maus

Klonalität

  • 129
  • 72
  • 3
Monoklonal

Konjugat

  • 108
  • 18
  • 13
  • 11
  • 9
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CTLA4 Antikörper ist unkonjugiert

Applikation

  • 96
  • 90
  • 63
  • 59
  • 45
  • 36
  • 18
  • 13
  • 10
  • 7
  • 6
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Western Blotting (WB), Immunofluorescence (IF)

Klon

L4P2F5-F10
  • Spezifität

    CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 Molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule.

    Kreuzreaktivität (Details)

    Cow, Cat, Mouse and Rat. Does not react with Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    A synthetic peptide from CTLA4 (exact sequence is proprietary)

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/million cells), ,Immunofluorescence (1-2 μg/mL), ,Western Blot (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.

    Positive_Control: Jurkat or Raji cells. Lymph node or tonsil.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Andere Bezeichnung

    CTLA4

    Hintergrund

    ALPS5, CD152, Celiac disease 3 (CELIAC3), Cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), GRD4, GSE, ICOS, Insulin-dependent Diabetes Mellitus 12 (IDDM12),CTLA4 / CD152 (Negative Regulator of T-Cells)
    Cellular localisation: Cell surface. Secreted.

    Molekulargewicht

    30-43kDa

    Gen-ID

    1493, 247824

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!